7 employees
VLPbio focuses on research and development of chimeric virus like particles (VLPs) as vaccines in animal and human health.
2012
$997K
from 3 investors over 3 rounds
VLPbio raised $997K on February 16, 2018
Investors: Inveready and Dyadic NL
VLPbio raised $56K on September 1, 2015
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)